The 3D Cell Culture 2023 conference will focus on advanced and predictive 3D cell culture models. Main topics of the 7th conference of the 3DCC series are latest trends in development, biology and applicationsof organoids, the biology in Microphysiological Systems, new developments in the field of Personalised Medicine, the path from 3D cell cultures to cell-based therapies, as well as enabling technologies for standardisation and scalability. In addition to scientific presentations, the exhibition will showcase practical applications, products and solutions and further stimulate discussion between researchers, solution providers and users.
Hahn-Schickard is exhibiting a platform for in vitro experiments with three-dimensional microtumors (spheroids and organoids) that will be used in the clinical setting for more targeted personalized tumor therapy. The platform is capable of high-throughput production of spheroids, sorting and separation of spheroids and organoids, and subsequent drug treatment. With the help of three-dimensional microtumors, the predictability of preclinical studies is to be optimized so that, on the one hand, more patient-specific active substances can be created or identified at the end and, on the other hand, the number of animal experiments can be minimized (Reduce).
For more information, please have a look here: https://www.hahn-schickard.de/en/projects/projects/3d-microtumor-analysis-for-personalized-therapy-adapt